Compare Agilent Technologies Inc (A) vs iShares MSCI Indonesia ETF (EIDO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs iShares MSCI Indonesia ETF — how do they compare? Agilent Technologies Inc trades at $128.14 (market cap $37.04B), while iShares MSCI Indonesia ETF trades at $11.7. The key difference: Agilent Technologies Inc pays a 0.78% dividend while iShares MSCI Indonesia ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals.
| A | EIDO | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | — |
52-Week High | $157.20 | $19.22 |
52-Week Low | $110.24 | $10.80 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
EIDO (iShares MSCI Indonesia ETF) trades at $11.81, up 3.14% today, but technical indicators show a bearish trend with selling pressure outweighing buying signals. The ETF faces headwinds from Indonesia's monetary policy tightening and dividend reductions, with key financial ratios currently unavailable for fundamental assessment. Recent news highlights Indonesia's economic initiatives including AI integration in government programs and reforestation efforts.
The outlook remains cautious as Bank Indonesia's rate hikes to defend the rupiah create currency volatility risks. While long-term GDP growth potential exists through government initiatives, near-term pressures from dividend cuts and technical bearishness suggest careful monitoring of Indonesian economic stability and ETF performance metrics is warranted for investors seeking emerging market exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares MSCI Indonesia ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →
